Cape Investment Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.1K | Buy |
2,871
+137
| +5% | +$2.3K | 0.02% | 371 |
|
|
2025
Q1 | $42K | Sell |
2,734
-124
| -4% | -$1.91K | 0.02% | 359 |
|
|
2024
Q4 | $63K | Hold |
2,858
| – | – | 0.02% | 304 |
|
|
2024
Q3 | $51.5K | Hold |
2,858
| – | – | 0.02% | 317 |
|
|
2024
Q2 | $46.4K | Hold |
2,858
| – | – | 0.02% | 303 |
|
|
2024
Q1 | $40.3K | Buy |
2,858
+144
| +5% | +$2.03K | 0.02% | 336 |
|
|
2023
Q4 | $28.3K | Hold |
2,714
| – | – | 0.01% | 467 |
|
|
2023
Q3 | $27.7K | Hold |
2,714
| – | – | 0.02% | 389 |
|
|
2023
Q2 | $20.4K | Buy |
2,714
+102
| +4% | +$768 | 0.01% | 432 |
|
|
2023
Q1 | $23.1K | Buy |
+2,612
| New | +$23.1K | 0.01% | 399 |
|